PAR 0.00% 21.0¢ paradigm biopharmaceuticals limited..

research reports and media, page-2417

  1. 2,143 Posts.
    lightbulb Created with Sketch. 576
    I really couldn’t GAF what Scott writes about PAR. All
    he does is point the finger at investors lack of patience but I’ve never seen one slight criticism on PAR management of which there are many.

    Michael Goldberg from CSVF at least assesses management well.

    that’s what happens when you are given 1M free shares by Paul Rennie to write positive stuff on the company.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.